OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications
Jianan Zhao, Kai Wei, Ping Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Hyperuricemia and its related diseases: mechanisms and advances in therapy
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 75

Role of NLRP3 in the pathogenesis and treatment of gout arthritis
Yaru Liu, Jiequan Wang, Jun Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62

Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?
Adrianna Gielecińska, Mateusz Kciuk, Esam Bashir Yahya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189024-189024
Open Access | Times Cited: 33

The role of pyroptosis in inflammatory diseases
Rong Chai, Ying Li, Linna Shui, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 29

Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice
Yueyi Zhang, Shan Wang, Xuan Dai, et al.
Journal of Ethnopharmacology (2023) Vol. 312, pp. 116530-116530
Closed Access | Times Cited: 18

Immune and inflammatory mechanisms and therapeutic targets of gout: An update
Wenji Liu, Jie Peng, Yixin Wu, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110466-110466
Closed Access | Times Cited: 16

Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets
Lin Wang, Xiaoyu Zhang, Jiayan Shen, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6

The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases
Siyu Wang, Hua Wang, Chengyao Feng, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 23

Monosodium Urate Crystal‐Induced Pyroptotic Cell Death in Neutrophil and Macrophage Facilitates the Pathological Progress of Gout
Chen Chen, Jingyun Wang, Yiyang Guo, et al.
Small (2023) Vol. 20, Iss. 23
Closed Access | Times Cited: 15

Electroacupuncture improves gout arthritis pain via attenuating ROS-mediated NLRP3 inflammasome overactivation
Huina Wei, Boyu Liu, Chengyu Yin, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 14

Traditional herbal medicine: Therapeutic potential in acute gouty arthritis
Siwei Wang, Wei Liu, Bowen Wei, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118182-118182
Open Access | Times Cited: 5

Neutrophil extracellular traps promote M1 macrophage polarization in gouty inflammation via targeting hexokinase-2
Haibo Tan, Shan Zhang, Zhihao Zhang, et al.
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 5

Dehydroisohispanolone Alleviates Nlrp3-Driven Inflammation in Gout Arthritis
Laura González‐Cofrade, Jack Green, Beatriz de las Heras, et al.
(2025)
Closed Access

Comparison of Pathophysiological Mechanisms Among Crystal-Induced Arthropathies
M. Zangari, Roberto Luisetto, Roberto Pilot, et al.
Gout Urate and Crystal Deposition Disease (2025) Vol. 3, Iss. 2, pp. 7-7
Open Access

Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4)
Marwa Qadri
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1425-1425
Open Access | Times Cited: 11

Gut-immunity-joint axis: a new therapeutic target for gouty arthritis
Pei‐Jer Chen, Zhiqiang Luo, Chengyin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach
Yedi Herdiana, Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 102-102
Open Access

Mechanism of NLRP3 inflammasome intervention for synovitis in knee osteoarthritis: A review of TCM intervention
Xianfu Han, Demin Lin, Weiwei Huang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 9

Gout Management Using Nanocarrier Systems: A Review
Chia Wen Qi, Ummu Umaimah Mohd Nordin, Syed Mahmood, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 9, pp. 9816-9846
Closed Access | Times Cited: 3

Advances in Gouty Arthritis Management: Integration of Established Therapies, Emerging Treatments, and Lifestyle Interventions
Ting-Kuo Yao, Ru‐Ping Lee, Wen‐Tien Wu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10853-10853
Open Access | Times Cited: 3

The inflammation process of gout arthritis and its treatment
Nita Parisa, Muhammad Totong Kamaluddin, Masagus Irsan Saleh, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2023) Vol. 14, Iss. 3, pp. 166-170
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top